Treatment
Treatment A clinical trials
We’re tracking 8,312 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT04556019Recruiting
Study of past and future liver and bile-pancreas surgeries
This is a research study using information from people who had certain liver, bile duct, and pancreas surgeries in the hospital’s surgical team. It aims to review surgical results and may help improve how these operations are done.
Pamplona, NavarreAges 15–90 - NCT02647879Recruiting
Preventing hepatitis C spread with treatment in Iceland
This study looks at giving hepatitis C treatment to people who test positive, to help prevent the infection from spreading. If you are 18 or older, live in Iceland, and can consent, you may be able to join.
ReykjavikAges 18 years+ - NCT04604626Recruiting
Study rare obesity linked to eating and brain conditions
This study aims to improve diagnosis and treatment planning for people with severe obesity—especially when it may be related to a genetic cause or a brain condition affecting appetite. You may be invited if your case includes clues from your history or symptoms, and you can consent to genetic testing discussions as part of usual care.
La DefenseAges Any age - NCT03825861RecruitingPhase 2
Before-surgery chemotherapy for locally advanced stomach cancer
This Phase 2 study tests chemotherapy given before surgery (called FOLFIRINOX) for people with locally advanced stomach cancer. The goal is to shrink the tumor and improve outcomes after the surgery plan is completed.
São PauloAges 18–75 - NCT04603222Recruiting
Testing a medicated eyelid brush for blepharitis
This trial tests the SUMMIT BRUSH to see if it helps treat blepharitis, an eyelid problem that can be linked to bacteria or tiny mites. It checks whether using the brush improves eyelid signs and symptoms in people who have specific visible findings on exam.
Boulder, ColoradoAges 18 years+ - NCT04382846RecruitingPhase 3
Testing new treatment combinations for COVID-19
This trial studies new drug treatment plans for people who currently have COVID-19. If it works better than standard care, it could improve recovery for patients.
TantaAges 18 years+ - NCT04653428Recruiting
German registry for repairing a severely leaky tricuspid valve
This study records patients who get a catheter-based repair for a severely leaky tricuspid heart valve. It helps doctors and researchers learn how these treatments work in real-world care.
MunichAges 18 years+ - NCT04376216RecruitingPhase 4
Prednisolone for biopsy-proven acute interstitial kidney inflammation
This trial tests whether prednisolone (a steroid medicine) helps people with acute interstitial nephritis, a sudden inflammation of the kidney tissue. You may qualify if your diagnosis was confirmed by kidney biopsy and your kidney function has worsened recently.
HerningAges 18 years+ - NCT04560907Recruiting
Aquablation versus laser procedure for enlarged prostate
This trial compares Aquablation with a laser procedure (HoLEP) to improve urinary symptoms caused by an enlarged, non-cancer prostate. It may help you understand which treatment works better for symptom relief in men with medium-to-large prostates.
Sankt GallenAges 45 years+ - NCT04045691Recruiting
Real-world targeted treatment for BRAF-mutant melanoma
This trial studies how doctors use encorafenib plus binimetinib for real-world care in people with BRAF V600–mutated melanoma that can’t be removed by surgery or has spread. It may help improve understanding of which patients benefit and what happens in everyday clinical practice.
GrazAges 18 years+ - NCT04351347RecruitingPhase 2/Phase 3
Testing higher-dose ivermectin for COVID-19
This trial studies whether a higher dose of ivermectin helps people with COVID-19. It looks at how well the treatment works and whether it causes side effects for participants.
TantaAges Any age - NCT03521648Recruiting
BPH treatment safety and effectiveness data collection
This trial collects information from people being treated for enlarged prostate (BPH) and related urinary symptoms to evaluate how well treatments work and how safe they are. It may help improve future care by better tracking real-world outcomes.
Sankt Gallen, Canton of St. GallenAges 18 years+ - NCT04733820RecruitingPhase 3
Extra chemo after surgery for advanced cervical cancer
This Phase 3 trial tests whether adding chemotherapy after surgery helps people with locally advanced cervical cancer, especially when prior treatment didn’t fully match standard guidelines. It looks at whether this “adjuvant” chemotherapy improves outcomes after neoadjuvant chemotherapy and an extensive hysterectomy.
Wuhan, HubeiAges 18–70 - NCT04766177RecruitingPhase 3
Bumetanide for children with autism symptoms
This trial tests whether bumetanide can improve autism symptoms in children. It is for children aged 3 to 12 with autism diagnosed using a standard symptom rating scale.
TantaAges 3–12 - NCT03136341RecruitingPhase 4
Dysport injections for task-specific hand tremor
This study tests whether injections of botulinum toxin (Dysport) can help people whose hand tremor only happens when they try to do specific tasks, like pouring a drink or eating. If you qualify, you would receive injections and be monitored to see if your tremor improves.
New York, New YorkAges 18–80 - NCT03961776Recruiting
MRI to monitor treatment response in rectal cancer
This trial tests whether an MRI scan done during chemoradiation can help doctors track how rectal cancer treatment is working. It may improve how they measure response early so treatment planning can be better tailored.
Los Angeles, CaliforniaAges 18 years+ - NCT03791034Recruiting
Blood DNA test to guide treatment in early lung cancer
This trial studies a “cell-free DNA” blood test to help diagnose and guide treatment decisions for early non-small cell lung cancer. It may help doctors tailor care based on genetic signals seen in the blood before and around surgery.
SeoulAges 18–90 - NCT04905056RecruitingPhase 2
Ablation treatment for lung ground-glass nodules that don’t go away
This Phase 2 trial studies whether a procedure called “ablation” is safe and effective for certain lung cancers that appear as ground-glass spots on CT scans and do not improve after 3 months. It may help people who cannot fully have surgery for their condition.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT04908566RecruitingPhase 2
PD-1 immunotherapy plus chemotherapy before and after gastric surgery
This trial studies whether adding a PD-1 immune therapy to chemotherapy around the time of surgery can improve outcomes for people with locally advanced stomach or stomach–esophagus junction cancer. It aims to better control the cancer before and reduce the chance it comes back after surgery.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT04903912Recruiting
Study of people with blocked blood vessels or aneurysms
This registry study follows people with peripheral artery disease (blocked leg arteries), certain carotid artery narrowing, or an abdominal aortic aneurysm. It may help doctors better understand these conditions and improve care over time.
NaplesAges 18–90 - NCT04911829Recruiting
Program for persistent low-grade depression and treatment changes
This trial looks at how treatment for persistent depressive disorder (long-lasting low mood) affects real-world costs and the process of changing treatments. It may help people who have tried some treatments before and need a practical plan moving forward.
Vikersund, BuskerudAges 18–70 - NCT03787056Recruiting
Blood test marker study in many cancer types
This study measures a blood marker called progastrin (at diagnosis and during treatment) to see how well it predicts response or outcomes. It may help doctors choose or monitor treatment more precisely for several cancer types.
BronAges 18 years+ - NCT04137653RecruitingPhase 3
New pre-surgery drug choice for triple-negative breast cancer
This trial tests which chemotherapy drug works better before surgery (neoadjuvant therapy) for triple-negative breast cancer that has spread to underarm lymph nodes. It compares two forms of paclitaxel given by random assignment to see which option may shrink the tumor more effectively and improve outcomes.
Shenyang, LiaoningAges 18–70 - NCT02073500Recruiting
Study of treatments and models for cancer in the belly lining
This study looks at how cancers that spread along the belly lining (“peritoneal surface malignancies”) behave and how different treatment strategies may work. It may help improve how doctors select and test treatments for people who are candidates for CRS-HIPEC, a specific cancer surgery approach.
OsloAges 18 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.